C0168IBD4020: A Phase 4, Multicenter, Open-label Study of Serum Infliximab Concentrations and Efficacy and Safety of Dose Escalation in Pediatric Patients with Inflammatory Bowel Disease

Project: Research project

Project Details

StatusFinished
Effective start/end date9/1/16 → 7/23/19

Funding

  • Janssen Research & Development, LLC